Loading organizations...
§ Private Profile · Durham, NC, USA
Developing next-generation fungicides using novel boron-based small molecules for crop protection, reducing fungicide resistance.
Boragen is an agricultural biotechnology company based in Durham, North Carolina, that develops next-generation fungicides and advanced crop protection solutions utilizing novel boron chemistry. The enterprise secured $10 million in Series A equity funding and research grants backed by prominent investors including the Bill and Melinda Gates Foundation, ARCH Venture Partners, and AgTech Accelerator. Operating with a core team of approximately 12 scientists, the organization focuses on reducing agricultural chemical usage per acre and combating widespread fungicide resistance. The company's proprietary research platform eventually expanded well beyond traditional agriculture, leading to the strategic spin-out of its crop protection division into a new entity called 5Metis alongside two separate stealth ventures in human and animal health. Boragen was founded in 2015 by Stephen Benkovic, C. Tony Liu, Lucy Shapiro, Gerald Fink, and Paul Schimmel.
Boragen has raised $10.0M across 1 funding round.
Boragen has raised $10.0M in total across 1 funding round.
Boragen has raised $10.0M in total across 1 funding round.
Boragen's investors include John Dombrosky, Joel Marcus, Kristina Burow, Bayer, Bill & Melinda Gates Foundation, Elanco Animal Health, Flagship Pioneering, Hatteras Venture Partners, Mountain Group Partners, Pappas Capital, Syngenta Ventures.
Boragen has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in March 2017.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 2, 2017 | $10M Series A | — | John Dombrosky, Joel Marcus, Kristina Burow, Bayer, Bill & Melinda Gates Foundation, Elanco Animal Health, Flagship Pioneering, Hatteras Venture Partners, Mountain Group Partners, Pappas Capital, Syngenta Ventures | Announced |